Literature DB >> 29260262

[Use of cannabinoids for chemotherapy-induced nausea and vomiting].

Désirée Louise Dräger1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29260262     DOI： 10.1007/s00120-017-0560-8

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


× No keyword cloud information.
  12 in total

Review 1.  Treatment of nausea and vomiting in advanced cancer.

Authors:  M P Davis; D Walsh
Journal:  Support Care Cancer       Date:  2000-11       Impact factor: 3.603

Review 2.  Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review.

Authors:  M R Tramèr; D Carroll; F A Campbell; D J Reynolds; R A Moore; H J McQuay
Journal:  BMJ       Date:  2001-07-07

Review 3.  Physiology of nausea and vomiting.

Authors:  P L Andrews
Journal:  Br J Anaesth       Date:  1992       Impact factor: 9.166

Review 4.  Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference.

Authors:  F Roila; J Herrstedt; M Aapro; R J Gralla; L H Einhorn; E Ballatori; E Bria; R A Clark-Snow; B T Espersen; P Feyer; S M Grunberg; P J Hesketh; K Jordan; M G Kris; E Maranzano; A Molassiotis; G Morrow; I Olver; B L Rapoport; C Rittenberg; M Saito; M Tonato; D Warr
Journal:  Ann Oncol       Date:  2010-05       Impact factor: 32.976

Review 5.  International antiemetic guidelines on chemotherapy induced nausea and vomiting (CINV): content and implementation in daily routine practice.

Authors:  Karin Jordan; Richard Gralla; Franziska Jahn; Alex Molassiotis
Journal:  Eur J Pharmacol       Date:  2013-10-21       Impact factor: 4.432

Review 6.  Antiemetics: American Society of Clinical Oncology clinical practice guideline update.

Authors:  Ethan Basch; Ann Alexis Prestrud; Paul J Hesketh; Mark G Kris; Petra C Feyer; Mark R Somerfield; Maurice Chesney; Rebecca Anne Clark-Snow; Anne Marie Flaherty; Barbara Freundlich; Gary Morrow; Kamakshi V Rao; Rowena N Schwartz; Gary H Lyman
Journal:  J Clin Oncol       Date:  2011-09-26       Impact factor: 44.544

7.  Chemotherapy-induced nausea and vomiting and antiemetic prophylaxis with palonosetron versus other 5-HT3 receptor antagonists in patients with cancer treated with low emetogenic chemotherapy in a hospital outpatient setting in the United States.

Authors:  Lee Schwartzberg; Gary Morrow; Sanjeev Balu; Chris Craver; Julie Gayle; David Cox
Journal:  Curr Med Res Opin       Date:  2011-06-22       Impact factor: 2.580

8.  Use of conjoint analysis to assess breast cancer patient preferences for chemotherapy side effects.

Authors:  Kathleen Beusterien; Jessica Grinspan; Iryna Kuchuk; Sasha Mazzarello; Susan Dent; Stan Gertler; Nathaniel Bouganim; Lisa Vandermeer; Mark Clemons
Journal:  Oncologist       Date:  2014-01-28

9.  Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study.

Authors:  Yolanda Escobar; Gerardo Cajaraville; Juan Antonio Virizuela; Rosa Álvarez; Andrés Muñoz; Olatz Olariaga; María José Tamés; Begoña Muros; María Jose Lecumberri; Jaime Feliu; Purificación Martínez; Juan Carlos Adansa; María José Martínez; Rafael López; Ana Blasco; Pere Gascón; Virginia Calvo; Pablo Luna; Joaquín Montalar; Patricia Del Barrio; María Victoria Tornamira
Journal:  Support Care Cancer       Date:  2015-06-17       Impact factor: 3.603

Review 10.  Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy.

Authors:  Lesley A Smith; Fredric Azariah; Verna T C Lavender; Nicola S Stoner; Silvana Bettiol
Journal:  Cochrane Database Syst Rev       Date:  2015-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.